CD274 and triple-negative breast carcinoma: PD-L1 copy number gains (CNG) are prevalent in significant subsets of different cancers including triple negative breast cancer [2], Hodgkin’s lymphoma [3], cancer of unknown primary [4], NSCLC [5], SCLC [6], and gastric cancer [7].